Zulresso Approved: A New Hope for Postpartum Depression Treatment

The approval of Zulresso, the first drug specifically developed to treat postpartum depression, could significantly change how doctors approach diagnosing and treating the condition.

Zulresso’s approval represents a crucial moment in maternal mental health, providing new hope for the numerous people facing postpartum depression—the most common complication of childbirth.